The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS' AI-powered analytics with MD Anderson's clinical and ...

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and ...

Questel, a world leader in intellectual property (IP) solutions, today launched its new AI-assisted Sophia Platform which includes Sophia Search, Document, Query and Lab solutions. Industry-leading ...

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today ...

Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

Investing.com -- Sophia Genetics SA (NASDAQ:SOPH) stock rose 4.2% on Wednesday after the AI-driven precision medicine company announced a strategic collaboration with The University of Texas MD ...

HOUSTON and BOSTON, JANUARY 7, 2026 ― The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics ...

PRNewswire/ -- (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today provided preliminary unaudited ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...